Young adults with myopia who attend school may benefit from lower concentration atropine, which minimizes visual performance disruptions.

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of ...

Purpose To assess the effect of weekly 1% atropine use on children’s myopia progression and whether the effect is sustainable. Methods Medical records of myopic children aged 3–15 years receiving ...

With defocus contact lenses on the market, research into future myopia management techniques narrow in on defocus spectacles ...

Objective: To compare atropine with placebo as an adjunct to ketamine sedation in children undergoing minor painful procedures. Outcome measures included hypersalivation, side effect profile, parental ...

The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.

Objectives Atropine sulfate eye drops are used to induce cycloplegia and mydriasis and therefore used in ocular penalisation as an alternative treatment to occlusion to treat amblyopia. 1 Service ...

0.05% atropine was associated with a higher incidence of mild side effects, though it was more effective in controlling myopia progression compared to 0.01% atropine or placebo. A new study published ...

SRINAGAR: In a major breakthrough, the doctors at GMC Rajouri have administered atropine to treat 11 patients who fell ill from a mysterious illness in Badhal village of J&K’s Rajouri.